Answer
The Neon Healthcare Ltd etoposide 50 mg soft capsule product is contraindicated in patients with hypersensitivity to etoposide, sodium ethyl parahydroxybenzoate (E215), sodium propyl parahydroxybenzoate (E217), or any excipient listed in section 6.1.
Sources for this answer
- Etoposide 50 mg capsule, softNeon Healthcare Ltd · emc · SmPC §4.3 Contraindications · Version 5Document updated
Sources checked